Literature DB >> 3760401

Clinical characteristics of cold-induced systemic reactions in acquired cold urticaria syndromes: recommendations for prevention of this complication and a proposal for a diagnostic classification of cold urticaria.

A A Wanderer, K E Grandel, S I Wasserman, R S Farr.   

Abstract

The acquired cold urticaria (ACU) syndromes consists of nonfamilial heterogeneous disorders characterized by urticaria, angioedema, and occasionally symptoms of hypotension after cold exposure. In a study of 50 consecutive patients with ACU syndromes, it was observed that 70% experienced cold-induced systemic reactions, most frequently with aquatic activities. Patients with ACU syndromes were categorized by their response to an experimental cold-stimulation time test (CSTT) i.e., minimum time threshold of cold stimulation required to induce a coalescent wheal. One subpopulation of patients with ACU syndromes with positive CSTTs of 3 minutes or less experienced the highest incidence (68%; 13/19) of severe systemic reactions with hypotensive symptoms after natural cold exposure. However, 32% of patients with ACU syndromes (6/19) who experienced cold-induced systemic reactions with hypotension had a negative CSTT or a positive test of greater than 3 minutes. These observations indicate that all patients with ACU with active histories of cold urticaria are at risk to develop systemic reactions to cold and should therefore refrain from participating in aquatic activities. In addition, high-risk patients should receive prophylactic medications (i.e., cyproheptadine or doxepin) that are effective in suppressing this disorder. A diagnostic classification of cold urticaria is presented. This classification permits a more specific definition of the various cold urticaria disorders that comprise the ACU syndromes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3760401     DOI: 10.1016/0091-6749(86)90027-8

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  13 in total

Review 1.  Review of Physical Urticarias and Testing Methods.

Authors:  Mario Sánchez-Borges; Luis González-Aveledo; Fernan Caballero-Fonseca; Arnaldo Capriles-Hulett
Journal:  Curr Allergy Asthma Rep       Date:  2017-08       Impact factor: 4.806

2.  [Sociomedical implications of the inability to commute in patients with cold urticaria].

Authors:  W Nürnberg; J Grabbe; H-J Glawe; R Stoll
Journal:  Hautarzt       Date:  2010-03       Impact factor: 0.751

3.  Cold-induced urticaria: challenges in diagnosis and management.

Authors:  Elana Fay Hochstadter; Moshe Ben-Shoshan
Journal:  BMJ Case Rep       Date:  2013-07-08

4.  Modern approaches to the diagnosis and treatment of cold contact urticaria.

Authors:  Karoline Krause; Torsten Zuberbier; Marcus Maurer
Journal:  Curr Allergy Asthma Rep       Date:  2010-07       Impact factor: 4.806

5.  Anaphylaxis in atypical cold urticaria: case report and review of literature.

Authors:  Elisa Benelli; Giorgio Longo; Egidio Barbi; Irene Berti
Journal:  Ital J Pediatr       Date:  2018-11-13       Impact factor: 2.638

6.  Management of cosmetic eyelid surgery complications.

Authors:  Stephen R Klapper; James R Patrinely
Journal:  Semin Plast Surg       Date:  2007-02       Impact factor: 2.314

Review 7.  Physical urticaria.

Authors:  Marina Abajian; Agnieszka Młynek; Marcus Maurer
Journal:  Curr Allergy Asthma Rep       Date:  2012-08       Impact factor: 4.806

8.  [Cold-induced urticaria and angioedema. Classification, diagnosis and therapy].

Authors:  K Krause; F Degener; S Altrichter; E Ardelean; D Kalogeromitros; M Magerl; M Metz; F Siebenhaar; K Weller; M Maurer
Journal:  Hautarzt       Date:  2010-09       Impact factor: 0.751

9.  Familial atypical cold urticaria: description of a new hereditary disease.

Authors:  Chhavi Gandhi; Chris Healy; Alan A Wanderer; Hal M Hoffman
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

10.  Treatment of severe cold contact urticaria with omalizumab: case reports.

Authors:  Petra Brodská; Peter Schmid-Grendelmeier
Journal:  Case Rep Dermatol       Date:  2012-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.